EX-10.26






 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 Exhibit 10.26 

Letter of Undertakings 
 To: the Board of
Directors of Lufax Holding Ltd. (hereinafter referred to as the “Proposed Listed Company”) 
 CC: 

Shenzhen Lukong Enterprise Management Co., Ltd. (hereinafter referred to as “Shenzhen Lukong”) 

I, [name of indirect individual shareholder], (i) hold [percentage]% equity interest in [name of an entity] (hereinafter referred to as “[Entity
1]”)[, and am the [general / limited] partner of [name of an entity] (hereinafter referred to as “[Entity 2]”) and hold [percentage]% property interest in [Entity 2]]. [Entity 1] directly holds [percentage]% equity interest
in Shenzhen Lukong [and [Entity 2] directly holds [percentage]% equity interest in Shenzhen Lukong]; and (ii) On November 21, 2018, I signed the Voting Proxy Agreement, the Exclusive Equity Interest Option Agreement, the Exclusive Asset
Option Agreement, and the Share Pledge Agreement (together with any written amendment, supplement or confirmation thereto made thereafter by the parties thereto (if any), collectively, “Relevant Shenzhen Lukong VIE Agreements”) with
Lukong (Shenzhen) Technology Service Co., Ltd. and other direct and indirect shareholders of Shenzhen Lukong. 
 In order to facilitate and complete the
listing of shares of the Proposed Listed Company on the Main Board of the Stock Exchange of Hong Kong Limited, I hereby confirm and irrevocably undertake that: 

1. Undertakings as to Death or Other Accidents 
 With
regard to the equity interest in Shenzhen Lukong indirectly held by me through [Entity 1] [and [Entity 2]] and all interests attached thereto (hereinafter referred to as “Relevant Equity Interest”), if I am deceased, lose the
capacity for civil conduct or otherwise, depriving me of the ability to perform my obligations under the Relevant Shenzhen Lukong VIE Agreements, the aforesaid Relevant Equity Interest held by me will be transferred, free of charge and
unconditionally, to the natural or legal person designated by Lukong (Shenzhen) Technology Service Co., Ltd. to the extent permitted by the PRC laws, meanwhile, the natural or legal person will succeed to all rights and obligations that I directly
or indirectly have and assume in Shenzhen Lukong. 
 2. Confirmation and Undertakings as to Divorce 

 

	(1)	 I confirm that the aforesaid Relevant Equity Interest is not the marital property, or owned by or at the
disposal of my spouse; 


  

	(2)	 My direct or indirect management of the operation of Shenzhen Lukong and other matters of Shenzhen Lukong
subject to voting (if I am involved) are not affected by my spouse; and 


  

	(3)	 If I divorce my spouse, I will take any action to procure the performance of the Relevant Shenzhen Lukong VIE
Agreements. I undertake that I shall not in any case take or commit any action, measure, or act that is contrary to the purpose or intention of the Relevant Shenzhen Lukong VIE Agreements. 



  
 1 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 3. Confirmation and Undertakings as to Conflicts of Interest 

 

	(1)	 I shall not in any case take or commit any action, measure, or act or omission that is contrary to the purpose
or intention of the Relevant Shenzhen Lukong VIE Agreements, which results in or may result in conflicts of interest between Shenzhen Lukong and the Proposed Listed Company, and its subsidiaries. 



 

	(2)	 If I have a conflict of interest with the Proposed Listed Company or its subsidiaries in performing the
Relevant Shenzhen Lukong VIE Agreements, I will safeguard legitimate rights and interests of Lukong (Shenzhen) Technology Service Co., Ltd. under the Relevant Shenzhen Lukong VIE Agreements and follow the instruction of the Proposed Listed Company.



 This letter of undertaking comes into force upon execution by me and shall remain valid. 

It is hereby undertaken as above. 
 (The
remainder of this page intentionally left blank) 

  
 2 


  














 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 Signature Page to the Letter of Undertakings 

Signature: /s/ [name of indirect individual shareholder] 

[name of indirect individual shareholder] 

Date: November 21, 2018